United States Point-Of-Care Or Rapid Diagnostics Market Report & Forecast 2021-2027

United States Point-Of-Care Or Rapid Diagnostics Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Point-Of-Care Or Rapid Diagnostics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Point-Of-Care Or Rapid Diagnostics Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Point-Of-Care Or Rapid Diagnostics Overall Market Size
2.1 United States Point-Of-Care Or Rapid Diagnostics Market Size: 2021 VS 2027
2.2 United States Point-Of-Care Or Rapid Diagnostics Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Point-Of-Care Or Rapid Diagnostics Sales: 2016-2027
3 Company Landscape
3.1 Top Point-Of-Care Or Rapid Diagnostics Players in United States Market
3.2 Top United States Point-Of-Care Or Rapid Diagnostics Companies Ranked by Revenue
3.3 United States Point-Of-Care Or Rapid Diagnostics Revenue by Companies
3.4 United States Point-Of-Care Or Rapid Diagnostics Sales by Companies
3.5 United States Point-Of-Care Or Rapid Diagnostics Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Point-Of-Care Or Rapid Diagnostics Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Point-Of-Care Or Rapid Diagnostics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Point-Of-Care Or Rapid Diagnostics Players in United States Market
3.8.1 List of Tier 1 Point-Of-Care Or Rapid Diagnostics Companies in United States
3.8.2 List of Tier 2 and Tier 3 Point-Of-Care Or Rapid Diagnostics Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Point-Of-Care Or Rapid Diagnostics Market Size Markets, 2021 & 2027
4.1.2 Intensive Care
4.1.3 Covid-19 Testing
4.1.4 Infectious Diseases Testing
4.1.5 Cardiac Markers Testing
4.1.6 Coagulation Testing
4.1.7 Others
4.2 By Type - United States Point-Of-Care Or Rapid Diagnostics Revenue & Forecasts
4.2.1 By Type - United States Point-Of-Care Or Rapid Diagnostics Revenue, 2016-2021
4.2.2 By Type - United States Point-Of-Care Or Rapid Diagnostics Revenue, 2022-2027
4.2.3 By Type - United States Point-Of-Care Or Rapid Diagnostics Revenue Market Share, 2016-2027
4.3 By Type - United States Point-Of-Care Or Rapid Diagnostics Sales & Forecasts
4.3.1 By Type - United States Point-Of-Care Or Rapid Diagnostics Sales, 2016-2021
4.3.2 By Type - United States Point-Of-Care Or Rapid Diagnostics Sales, 2022-2027
4.3.3 By Type - United States Point-Of-Care Or Rapid Diagnostics Sales Market Share, 2016-2027
4.4 By Type - United States Point-Of-Care Or Rapid Diagnostics Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Point-Of-Care Or Rapid Diagnostics Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Independent Laboratories
5.1.5 Others
5.2 By Application - United States Point-Of-Care Or Rapid Diagnostics Revenue & Forecasts
5.2.1 By Application - United States Point-Of-Care Or Rapid Diagnostics Revenue, 2016-2021
5.2.2 By Application - United States Point-Of-Care Or Rapid Diagnostics Revenue, 2022-2027
5.2.3 By Application - United States Point-Of-Care Or Rapid Diagnostics Revenue Market Share, 2016-2027
5.3 By Application - United States Point-Of-Care Or Rapid Diagnostics Sales & Forecasts
5.3.1 By Application - United States Point-Of-Care Or Rapid Diagnostics Sales, 2016-2021
5.3.2 By Application - United States Point-Of-Care Or Rapid Diagnostics Sales, 2022-2027
5.3.3 By Application - United States Point-Of-Care Or Rapid Diagnostics Sales Market Share, 2016-2027
5.4 By Application - United States Point-Of-Care Or Rapid Diagnostics Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Overview
6.1.3 Roche Point-Of-Care Or Rapid Diagnostics Sales and Revenue in United States Market (2016-2021)
6.1.4 Roche Point-Of-Care Or Rapid Diagnostics Product Description
6.1.5 Roche Recent Developments
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Overview
6.2.3 Abbott Point-Of-Care Or Rapid Diagnostics Sales and Revenue in United States Market (2016-2021)
6.2.4 Abbott Point-Of-Care Or Rapid Diagnostics Product Description
6.2.5 Abbott Recent Developments
6.3 Danaher
6.3.1 Danaher Corporation Information
6.3.2 Danaher Overview
6.3.3 Danaher Point-Of-Care Or Rapid Diagnostics Sales and Revenue in United States Market (2016-2021)
6.3.4 Danaher Point-Of-Care Or Rapid Diagnostics Product Description
6.3.5 Danaher Recent Developments
6.4 Siemens Healthcare
6.4.1 Siemens Healthcare Corporation Information
6.4.2 Siemens Healthcare Overview
6.4.3 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales and Revenue in United States Market (2016-2021)
6.4.4 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product Description
6.4.5 Siemens Healthcare Recent Developments
6.5 Bio-Rad Laboratories
6.5.1 Bio-Rad Laboratories Corporation Information
6.5.2 Bio-Rad Laboratories Overview
6.5.3 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales and Revenue in United States Market (2016-2021)
6.5.4 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product Description
6.5.5 Bio-Rad Laboratories Recent Developments
6.6 BioMerieux
6.6.1 BioMerieux Corporation Information
6.6.2 BioMerieux Overview
6.6.3 BioMerieux Point-Of-Care Or Rapid Diagnostics Sales and Revenue in United States Market (2016-2021)
6.6.4 BioMerieux Point-Of-Care Or Rapid Diagnostics Product Description
6.6.5 BioMerieux Recent Developments
6.7 Nova Biomedical
6.7.1 Nova Biomedical Corporation Information
6.7.2 Nova Biomedical Overview
6.7.3 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales and Revenue in United States Market (2016-2021)
6.7.4 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product Description
6.7.5 Nova Biomedical Recent Developments
6.8 Thermo Fisher Scientific
6.8.1 Thermo Fisher Scientific Corporation Information
6.8.2 Thermo Fisher Scientific Overview
6.8.3 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales and Revenue in United States Market (2016-2021)
6.8.4 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product Description
6.8.5 Thermo Fisher Scientific Recent Developments
6.9 Quidel
6.9.1 Quidel Corporation Information
6.9.2 Quidel Overview
6.9.3 Quidel Point-Of-Care Or Rapid Diagnostics Sales and Revenue in United States Market (2016-2021)
6.9.4 Quidel Point-Of-Care Or Rapid Diagnostics Product Description
6.9.5 Quidel Recent Developments
6.10 A. Menarini Diagnostics
6.10.1 A. Menarini Diagnostics Corporation Information
6.10.2 A. Menarini Diagnostics Overview
6.10.3 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales and Revenue in United States Market (2016-2021)
6.10.4 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product Description
6.10.5 A. Menarini Diagnostics Recent Developments
6.11 Becton Dickinson
6.11.1 Becton Dickinson Corporation Information
6.11.2 Becton Dickinson Overview
6.11.3 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales and Revenue in United States Market (2016-2021)
6.11.4 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product Description
6.11.5 Becton Dickinson Recent Developments
6.12 Biosurfit
6.12.1 Biosurfit Corporation Information
6.12.2 Biosurfit Overview
6.12.3 Biosurfit Point-Of-Care Or Rapid Diagnostics Sales and Revenue in United States Market (2016-2021)
6.12.4 Biosurfit Point-Of-Care Or Rapid Diagnostics Product Description
6.12.5 Biosurfit Recent Developments
6.13 Astrego Diagnostics
6.13.1 Astrego Diagnostics Corporation Information
6.13.2 Astrego Diagnostics Overview
6.13.3 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales and Revenue in United States Market (2016-2021)
6.13.4 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product Description
6.13.5 Astrego Diagnostics Recent Developments
6.14 Werfen
6.14.1 Werfen Corporation Information
6.14.2 Werfen Overview
6.14.3 Werfen Point-Of-Care Or Rapid Diagnostics Sales and Revenue in United States Market (2016-2021)
6.14.4 Werfen Point-Of-Care Or Rapid Diagnostics Product Description
6.14.5 Werfen Recent Developments
6.15 Abionic
6.15.1 Abionic Corporation Information
6.15.2 Abionic Overview
6.15.3 Abionic Point-Of-Care Or Rapid Diagnostics Sales and Revenue in United States Market (2016-2021)
6.15.4 Abionic Point-Of-Care Or Rapid Diagnostics Product Description
6.15.5 Abionic Recent Developments
6.16 Palex Medical/Bülhmann
6.16.1 Palex Medical/Bülhmann Corporation Information
6.16.2 Palex Medical/Bülhmann Overview
6.16.3 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales and Revenue in United States Market (2016-2021)
6.16.4 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product Description
6.16.5 Palex Medical/Bülhmann Recent Developments
6.17 Horiba Medical
6.17.1 Horiba Medical Corporation Information
6.17.2 Horiba Medical Overview
6.17.3 Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales and Revenue in United States Market (2016-2021)
6.17.4 Horiba Medical Point-Of-Care Or Rapid Diagnostics Product Description
6.17.5 Horiba Medical Recent Developments
6.18 RAL
6.18.1 RAL Corporation Information
6.18.2 RAL Overview
6.18.3 RAL Point-Of-Care Or Rapid Diagnostics Sales and Revenue in United States Market (2016-2021)
6.18.4 RAL Point-Of-Care Or Rapid Diagnostics Product Description
6.18.5 RAL Recent Developments
6.19 Vircell
6.19.1 Vircell Corporation Information
6.19.2 Vircell Overview
6.19.3 Vircell Point-Of-Care Or Rapid Diagnostics Sales and Revenue in United States Market (2016-2021)
6.19.4 Vircell Point-Of-Care Or Rapid Diagnostics Product Description
6.19.5 Vircell Recent Developments
6.20 Monlab
6.20.1 Monlab Corporation Information
6.20.2 Monlab Overview
6.20.3 Monlab Point-Of-Care Or Rapid Diagnostics Sales and Revenue in United States Market (2016-2021)
6.20.4 Monlab Point-Of-Care Or Rapid Diagnostics Product Description
6.20.5 Monlab Recent Developments
6.21 Binding Site
6.21.1 Binding Site Corporation Information
6.21.2 Binding Site Overview
6.21.3 Binding Site Point-Of-Care Or Rapid Diagnostics Sales and Revenue in United States Market (2016-2021)
6.21.4 Binding Site Point-Of-Care Or Rapid Diagnostics Product Description
6.21.5 Binding Site Recent Developments
7 United States Point-Of-Care Or Rapid Diagnostics Production Capacity, Analysis
7.1 United States Point-Of-Care Or Rapid Diagnostics Production Capacity, 2016-2027
7.2 Point-Of-Care Or Rapid Diagnostics Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Point-Of-Care Or Rapid Diagnostics Supply Chain Analysis
9.1 Point-Of-Care Or Rapid Diagnostics Industry Value Chain
9.2 Point-Of-Care Or Rapid Diagnostics Upstream Market
9.3 Point-Of-Care Or Rapid Diagnostics Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Point-Of-Care Or Rapid Diagnostics Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Point-Of-Care Or Rapid Diagnostics in United States Market
Table 2. Top Point-Of-Care Or Rapid Diagnostics Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Point-Of-Care Or Rapid Diagnostics Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Point-Of-Care Or Rapid Diagnostics Revenue Share by Companies, 2016-2021
Table 5. United States Point-Of-Care Or Rapid Diagnostics Sales by Companies, (K Doses), 2016-2021
Table 6. United States Point-Of-Care Or Rapid Diagnostics Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Point-Of-Care Or Rapid Diagnostics Price (2016-2021) & (US$/Dose)
Table 8. Manufacturers Point-Of-Care Or Rapid Diagnostics Product Type
Table 9. List of Tier 1 Point-Of-Care Or Rapid Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Point-Of-Care Or Rapid Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Intensive Care
Table 12. Major Manufacturers of Covid-19 Testing
Table 13. By Type - United States Point-Of-Care Or Rapid Diagnostics Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Point-Of-Care Or Rapid Diagnostics Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Point-Of-Care Or Rapid Diagnostics Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Point-Of-Care Or Rapid Diagnostics Sales (K Doses), 2016-2021
Table 17. By Type - United States Point-Of-Care Or Rapid Diagnostics Sales (K Doses), 2022-2027
Table 18. By Application - United States Point-Of-Care Or Rapid Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Point-Of-Care Or Rapid Diagnostics Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Point-Of-Care Or Rapid Diagnostics Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Point-Of-Care Or Rapid Diagnostics Sales (K Doses), 2016-2021
Table 22. By Application - United States Point-Of-Care Or Rapid Diagnostics Sales (K Doses), 2022-2027
Table 23. Roche Corporation Information
Table 24. Roche Description and Major Businesses
Table 25. Roche Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 26. Roche Point-Of-Care Or Rapid Diagnostics Product
Table 27. Roche Recent Developments
Table 28. Abbott Corporation Information
Table 29. Abbott Description and Major Businesses
Table 30. Abbott Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 31. Abbott Point-Of-Care Or Rapid Diagnostics Product
Table 32. Abbott Recent Developments
Table 33. Danaher Corporation Information
Table 34. Danaher Description and Major Businesses
Table 35. Danaher Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 36. Danaher Point-Of-Care Or Rapid Diagnostics Product
Table 37. Danaher Recent Developments
Table 38. Siemens Healthcare Corporation Information
Table 39. Siemens Healthcare Description and Major Businesses
Table 40. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 41. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product
Table 42. Siemens Healthcare Recent Developments
Table 43. Bio-Rad Laboratories Corporation Information
Table 44. Bio-Rad Laboratories Description and Major Businesses
Table 45. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 46. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product
Table 47. Bio-Rad Laboratories Recent Developments
Table 48. BioMerieux Corporation Information
Table 49. BioMerieux Description and Major Businesses
Table 50. BioMerieux Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 51. BioMerieux Point-Of-Care Or Rapid Diagnostics Product
Table 52. BioMerieux Recent Developments
Table 53. Nova Biomedical Corporation Information
Table 54. Nova Biomedical Description and Major Businesses
Table 55. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 56. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product
Table 57. Nova Biomedical Recent Developments
Table 58. Thermo Fisher Scientific Corporation Information
Table 59. Thermo Fisher Scientific Description and Major Businesses
Table 60. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 61. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product
Table 62. Thermo Fisher Scientific Recent Developments
Table 63. Quidel Corporation Information
Table 64. Quidel Description and Major Businesses
Table 65. Quidel Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 66. Quidel Point-Of-Care Or Rapid Diagnostics Product
Table 67. Quidel Recent Developments
Table 68. A. Menarini Diagnostics Corporation Information
Table 69. A. Menarini Diagnostics Description and Major Businesses
Table 70. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 71. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product
Table 72. A. Menarini Diagnostics Recent Developments
Table 73. Becton Dickinson Corporation Information
Table 74. Becton Dickinson Description and Major Businesses
Table 75. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 76. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product
Table 77. Becton Dickinson Recent Developments
Table 78. Biosurfit Corporation Information
Table 79. Biosurfit Description and Major Businesses
Table 80. Biosurfit Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 81. Biosurfit Point-Of-Care Or Rapid Diagnostics Product
Table 82. Biosurfit Recent Developments
Table 83. Astrego Diagnostics Corporation Information
Table 84. Astrego Diagnostics Description and Major Businesses
Table 85. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 86. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product
Table 87. Astrego Diagnostics Recent Developments
Table 88. Werfen Corporation Information
Table 89. Werfen Description and Major Businesses
Table 90. Werfen Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 91. Werfen Point-Of-Care Or Rapid Diagnostics Product
Table 92. Werfen Recent Developments
Table 93. Abionic Corporation Information
Table 94. Abionic Description and Major Businesses
Table 95. Abionic Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 96. Abionic Point-Of-Care Or Rapid Diagnostics Product
Table 97. Abionic Recent Developments
Table 98. Palex Medical/Bülhmann Corporation Information
Table 99. Palex Medical/Bülhmann Description and Major Businesses
Table 100. Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 101. Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product
Table 102. Palex Medical/Bülhmann Recent Developments
Table 103. Horiba Medical Corporation Information
Table 104. Horiba Medical Description and Major Businesses
Table 105. Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 106. Horiba Medical Point-Of-Care Or Rapid Diagnostics Product
Table 107. Horiba Medical Recent Developments
Table 108. RAL Corporation Information
Table 109. RAL Description and Major Businesses
Table 110. RAL Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 111. RAL Point-Of-Care Or Rapid Diagnostics Product
Table 112. RAL Recent Developments
Table 113. Vircell Corporation Information
Table 114. Vircell Description and Major Businesses
Table 115. Vircell Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 116. Vircell Point-Of-Care Or Rapid Diagnostics Product
Table 117. Vircell Recent Developments
Table 118. Monlab Corporation Information
Table 119. Monlab Description and Major Businesses
Table 120. Monlab Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 121. Monlab Point-Of-Care Or Rapid Diagnostics Product
Table 122. Monlab Recent Developments
Table 123. Binding Site Corporation Information
Table 124. Binding Site Description and Major Businesses
Table 125. Binding Site Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$, Mn) and Gross Margin (US$/Dose) (2016-2021)
Table 126. Binding Site Point-Of-Care Or Rapid Diagnostics Product
Table 127. Binding Site Recent Developments
Table 128. Point-Of-Care Or Rapid Diagnostics Production Capacity (K Doses) of Key Manufacturers in United States Market, 2019-2021 (K Doses)
Table 129. United States Point-Of-Care Or Rapid Diagnostics Capacity Market Share of Key Manufacturers, 2019-2021
Table 130. Point-Of-Care Or Rapid Diagnostics Market Opportunities & Trends in United States Market
Table 131. Point-Of-Care Or Rapid Diagnostics Market Drivers in United States Market
Table 132. Point-Of-Care Or Rapid Diagnostics Market Restraints in United States Market
Table 133. Point-Of-Care Or Rapid Diagnostics Raw Materials
Table 134. Point-Of-Care Or Rapid Diagnostics Raw Materials Suppliers in United States Market
Table 135. Typical Point-Of-Care Or Rapid Diagnostics Downstream
Table 136. Point-Of-Care Or Rapid Diagnostics Downstream Clients in United States Market
Table 137. Point-Of-Care Or Rapid Diagnostics Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Point-Of-Care Or Rapid Diagnostics Product Picture
Figure 2. Point-Of-Care Or Rapid Diagnostics Segment by Type
Figure 3. Point-Of-Care Or Rapid Diagnostics Segment by Application
Figure 4. United States Point-Of-Care Or Rapid Diagnostics Market Overview: 2020
Figure 5. United States Point-Of-Care Or Rapid Diagnostics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Point-Of-Care Or Rapid Diagnostics Revenue, 2016-2027 (US$, Mn)
Figure 7. Point-Of-Care Or Rapid Diagnostics Sales in United States Market: 2016-2027 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Point-Of-Care Or Rapid Diagnostics Revenue in 2020
Figure 9. Intensive Care Product Picture
Figure 10. Covid-19 Testing Product Picture
Figure 11. Infectious Diseases Testing Product Picture
Figure 12. Cardiac Markers Testing Product Picture
Figure 13. Coagulation Testing Product Picture
Figure 14. By Type - United States Point-Of-Care Or Rapid Diagnostics Sales Market Share, 2016-2027
Figure 15. By Type - United States Point-Of-Care Or Rapid Diagnostics Revenue Market Share, 2016-2027
Figure 16. By Type - United States Point-Of-Care Or Rapid Diagnostics Price (US$/Dose), 2016-2027
Figure 17. Hospital
Figure 18. Clinic
Figure 19. Independent Laboratories
Figure 20. Others
Figure 21. By Application - United States Point-Of-Care Or Rapid Diagnostics Sales Market Share, 2016-2027
Figure 22. By Application - United States Point-Of-Care Or Rapid Diagnostics Revenue Market Share, 2016-2027
Figure 23. By Application - United States Point-Of-Care Or Rapid Diagnostics Price (US$/Dose), 2016-2027
Figure 24. Roche Point-Of-Care Or Rapid Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Abbott Point-Of-Care Or Rapid Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Danaher Point-Of-Care Or Rapid Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. BioMerieux Point-Of-Care Or Rapid Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Quidel Point-Of-Care Or Rapid Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Biosurfit Point-Of-Care Or Rapid Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. Werfen Point-Of-Care Or Rapid Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Abionic Point-Of-Care Or Rapid Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Horiba Medical Point-Of-Care Or Rapid Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. RAL Point-Of-Care Or Rapid Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Vircell Point-Of-Care Or Rapid Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Monlab Point-Of-Care Or Rapid Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Binding Site Point-Of-Care Or Rapid Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. United States Point-Of-Care Or Rapid Diagnostics Production Capacity (K Doses), 2016-2027
Figure 46. Point-Of-Care Or Rapid Diagnostics Industry Value Chain
Figure 47. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs